SPONSOR
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Total Trials
3
Recruiting
3
Phases
Phase 2, Phase 3
Conditions studied: Neoadjuvant TherapyHigh Risk Prostate CancerLocally Advanced Prostate CancerIntense Endocrine TherapyAortic DissectionInflammationSudden Cardiac DeathExosome MultiomicsClinical Prognosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer, Intense Endocrine Therapy.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
How many clinical trials has The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, of which 3 are actively recruiting participants. These trials cover conditions including Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School research focus on?
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School clinical trials span Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer, Intense Endocrine Therapy, Aortic Dissection, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School clinical trial?
To participate in a The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials with current recruitment status updated daily.
Clinical Trials by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NCT05406999 Phase 2
Recruiting
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Neoadjuvant Therapy
NCT06968806 Phase 3
Recruiting
Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection
Aortic Dissection
NCT06856993
Recruiting
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
Sudden Cardiac Death
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology